logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
P

Pavel Mozgunov

MRC Biostatistics Unit
H指数:12
被引数:568

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Optimal Dose and Safety of Intravenous Favipiravir in Hospitalized Patients With COVID-19: A Dose-Escalating, Randomized Controlled Phase Ib Study

奥普米gia静脉注射给药在住院COVID-19患者中的最佳剂量与安全性：一项剂量递增、随机对照的Ib期研究

CLINICAL PHARMACOLOGY & THERAPEUTICS
IF5.5
2026-03-180
OAAI
Tim Rowland; Richard FitzGerald; Elizabeth Challenger; Laura Dickinson; Laura J. Else; Lauren Walker; Colin Hale; Victoria Shaw; Callum Kelly; Rebecca Lyon; Jennifer Gibney; Karim Dhamani; Margaret Irwin; Yvanne Enever; Michelle Tetlow; William Wood; Helen Reynolds; Justin Chiong; Orod Osanlou; Henry Pertinez; Katie Bullock; William Greenhalf; Andrew Owen; David G. Lalloo; Michael Jacobs; Julian A. Hiscox; Thomas Jaki; Pavel Mozgunov; Geoffrey Saunders; Gareth Griffiths; Saye H. Khoo; Thomas E. Fletcher; the AGILE CST-6 Study Group
Cancer Research UK phase I/IIa trial of the prostaglandin E2 (PGE2) receptor 4 (EP4) antagonist HTL0039732 as monotherapy and in combination with immunotherapy in patients (pts) with advanced solid tumors

英国癌症研究（Cancer Research UK）I/IIa期临床试验，评估前列腺素E2（PGE2）受体4（EP4）拮抗剂HTL0039732作为单药治疗及联合免疫疗法在晚期实体瘤患者（pts）中的应用。

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Sarker, D.; Cook, N.; Leung, C.; Aktas, B. Y.; Dawson, R. C.; Demeris, N.; Mozgunov, P.; Howe, D.; Austin, N.; Swain, N.; Leader, I. P.; Manage, A.; Azizi, A.; Halbert, G. W.; Brotherton, L.; Svetlik, S.; Westwood, N. B.; Paisley, D.; Symeonides, S. N.; Basu, B.
Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised, placebo-controlled, double-blind, phase 2 trial
LANCET INFECTIOUS DISEASES
IF31
2023-02-0161
OAAI
Khoo, Saye H.; FitzGerald, Richard; Saunders, Geoffrey; Middleton, Calley; Ahmad, Shazaad; Edwards, Christopher J.; Hadjiyiannakis, Dennis; Walker, Lauren; Lyon, Rebecca; Shaw, Victoria; Mozgunov, Pavel; Periselneris, Jimstan; Woods, Christie; Bullock, Katie; Hale, Colin; Reynolds, Helen; Downs, Nichola; Ewings, Sean; Buadi, Amanda; Cameron, David; Edwards, Thomas; Knox, Emma; Donovan-Banfield, I'ah; Greenhalf, William; Chiong, Justin; Lavelle-Langham, Lara; Jacobs, Michael; Northey, Josh; Painter, Wendy; Holman, Wayne; Lalloo, David G.; Tetlow, Michelle; Hiscox, Julian A.; Jaki, Thomas; Fletcher, Thomas; Griffiths, Gareth
An Open Label, Adaptive, Phase 1 Trial of High-Dose Oral Nitazoxanide in Healthy Volunteers: An Antiviral Candidate for SARS-CoV-2
CLINICAL PHARMACOLOGY & THERAPEUTICS
IF5.5
2021-11-1314
OAAI
Walker, Lauren E.; FitzGerald, Richard; Saunders, Geoffrey; Lyon, Rebecca; Fisher, Michael; Martin, Karen; Eberhart, Izabela; Woods, Christie; Ewings, Sean; Hale, Colin; Rajoli, Rajith K. R.; Else, Laura; Dilly-Penchala, Sujan; Amara, Alieu; Lalloo, David G.; Jacobs, Michael; Pertinez, Henry; Hatchard, Parys; Waugh, Robert; Lawrence, Megan; Johnson, Lucy; Fines, Keira; Reynolds, Helen; Rowland, Timothy; Crook, Rebecca; Okenyi, Emmanuel; Byrne, Kelly; Mozgunov, Pavel; Jaki, Thomas; Khoo, Saye; Owen, Andrew; Griffiths, Gareth; Fletcher, Thomas E.
Optimal dose and safety of molnupiravir in patients with early SARS-CoV-2: a Phase I, open-label, dose-escalating, randomized controlled study
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
IF3.6
2021-08-2783
OAAI
Khoo, Saye H.; Fitzgerald, Richard; Fletcher, Thomas; Ewings, Sean; Jaki, Thomas; Lyon, Rebecca; Downs, Nichola; Walker, Lauren; Tansley-Hancock, Olana; Greenhalf, William; Woods, Christie; Reynolds, Helen; Marwood, Ellice; Mozgunov, Pavel; Adams, Emily; Bullock, Katie; Holman, Wayne; Bula, Marcin D.; Gibney, Jennifer L.; Saunders, Geoffrey; Corkhill, Andrea; Hale, Colin; Thorne, Kerensa; Chiong, Justin; Condie, Susannah; Pertinez, Henry; Painter, Wendy; Wrixon, Emma; Johnson, Lucy; Yeats, Sara; Mallard, Kim; Radford, Mike; Fines, Keira; Shaw, Victoria; Owen, Andrew; Lalloo, David G.; Jacobs, Michael; Griffiths, Gareth

研究方向

暂未获取到该数据
J
Jaki, Thomas
H 指数:0论文数:2被引数:0
G
Gareth Griffiths
H 指数:68论文数:542被引数:2.1万
D
David G. Lalloo
H 指数:69论文数:460被引数:2.0万
S
Sean Ewings
H 指数:24论文数:93被引数:2,118
H
Helen Reynolds
H 指数:23论文数:88被引数:2,634
C
Colin Hale
H 指数:17论文数:61被引数:1,139
R
Rebecca Lyon
H 指数:12论文数:38被引数:599
S
Saye Khoo
H 指数:72论文数:544被引数:2.2万
R
Richard J. Fitzgerald
H 指数:83论文数:618被引数:2.2万
M
Michael Jacobs
H 指数:47论文数:182被引数:1.2万